Search the Newsreel

Weyerhaeuser beats Q2 estimates on strong wood products demand

Weyerhaeuser (NYSE:WY) reported strong second-quarter results, beating analyst estimates for both EPS and revenue, primarily driven by robust demand in its Wood Products segment. Despite a slight decrease in overall revenue year-over-year, the company saw sales realizations for lumber and oriented strand board increase …

WEYERHAEUSER ($WY) Releases Q2 2026 Earnings, Stock Rises

Weyerhaeuser (WY) reported its Q2 2026 earnings, with an EPS of $0.13, beating estimates, despite revenue of $1.867 billion missing expectations. Following the announcement, the stock saw a 1.66% increase. The article also details recent insider trading activities, significant hedge fund movements, and current …

Weyerhaeuser (WY) Tops Q2 EPS by 3c; offers outlook

Weyerhaeuser (WY) reported strong Q2 earnings, surpassing analyst estimates with an EPS of $0.13, $0.03 higher than predicted, and revenue of $1.87 billion, exceeding the consensus of $1.84 billion. The company also provided a Q3 2026 outlook, anticipating a slight dip in earnings and …

Weyerhaeuser Will Discuss Q2 Results in July 31 Webcast

Weyerhaeuser (NYSE: WY) has released its second-quarter 2026 financial results, which are available on its website and via an 8-K filing with the SEC. The company will host a live webcast and conference call on July 31, 2026, at 7 a.m. Pacific (10 a.m. …

Earnings Preview: Haemonetics (HAE) Q1 Earnings Expected to Decline

Haemonetics (HAE) is expected to report a year-over-year decline in Q1 earnings to $1.07 per share, despite a projected 2% increase in revenues to $327.95 million. The consensus EPS estimate has been revised slightly lower, and the company currently holds a Zacks Rank #4 …

HAE|Haemonetics Corp|Price:85.430|Chg%:+2.890

Haemonetics Corp (HAE) shows healthy fundamentals and high growth potential, with its valuation considered fairly valued within the Healthcare Equipment & Supplies industry. Analysts have rated it a "Buy" with a target price of $89.33, and the stock is expected to trend upwards in …

Haemonetics (HAE) Projected to Announce Quarterly Earnings on Thursday

Michael Hill hails sales growth, but its Australian and Canadian stores outperform New Zealand

Weyerhaeuser (WY) Earnings Date and Reports 2026 $WY

Haemonetics (NYSE: HAE) director receives 2,538 RSUs equity award

Haemonetics Corp director Lloyd Emerson Johnson was granted 2,538 restricted stock units (RSUs) on July 24, 2026, which will vest 100% on the first anniversary of the grant date. Following this award, Johnson's direct holdings in common stock total 15,471 shares. The RSUs were …

Haemonetics (NYSE: HAE) director awarded 2,538 RSUs vesting in one year

Haemonetics Corp director Martin D. Madaus was granted 2,538 restricted stock units (RSUs) on July 24, 2026, which will vest 100% on the first anniversary of the grant date. Each RSU represents a contingent right to receive one share of common stock. After this …

Michael Hill (ASX:MHJ) - Rising gold costs: How this impacts jewellery retailer's outlook

Martin D. Madaus insider status at Haemonetics (NYSE: HAE) disclosed

Haemonetics Corp. announced that Martin D. Madaus has been identified as a director and reporting person for the company's equity securities. According to the Form 3 filing, Madaus currently holds no shares, has executed no buy or sell transactions, and has no derivative positions. …

Haemonetics (NYSE: HAE) awards director 2,538 RSUs vesting on first anniversary

Haemonetics (NYSE: HAE) director Mark W. Kroll was granted 2,538 restricted stock units (RSUs) under the company's 2019 Long-Term Incentive Compensation Plan. These RSUs will vest 100% on their first anniversary, with each RSU representing one share of common stock upon vesting. Following this …

Weyerhaeuser Co. stock underperforms Tuesday when compared to competitors despite daily gains

Weyerhaeuser Co. stock rallied 2.93% on Tuesday, closing at $24.61, but still underperformed compared to its competitors. The company's stock closed 11.32% below its 52-week high of $27.75. This occurred during a generally positive trading session for the stock market, with both the S&P …

Weyerhaeuser Co expected to post earnings of 9 cents a share - Earnings Preview

Weyerhaeuser Co (WY) is expected to announce earnings of 9 cents per share. This information comes from an earnings preview provided by Refinitiv. The full article is accessible on TradingView, which aggregates news from various sources including Reuters.

Haemonetics Corporation Revenue Breakdown – SWB:HAZ

Haemonetics Corporation (SWB:HAZ) generated 1.15 billion EUR in revenue last year. Its top-performing segment was Hospital, contributing 509.19 million EUR, and the United States was the greatest regional contributor with 850.10 million EUR. This article provides a breakdown of the company's revenue by segment …

Haemonetics Corp (NYSE: HAE) grants director Diane Bryant 2,538 restricted stock units

Haemonetics Corp (NYSE: HAE) director Diane M. Bryant was granted 2,538 restricted stock units (RSUs) on July 24, 2026, as part of the company's 2019 Long-Term Incentive Compensation Plan. These RSUs will vest 100% one year from the grant date, with each unit representing …

Haemonetics Corp (NYSE: HAE) grants 2,538 RSUs to board director

Haemonetics Corp (NYSE: HAE) director Claire Pomeroy was granted 2,538 restricted stock units (RSUs) on July 24, 2026, as reported in a recent Form 4 SEC filing. These RSUs, part of the company's 2019 Long-Term Incentive Compensation Plan, will vest 100% on the first …

Haemonetics elects Martin Madaus to board of directors

Haemonetics Corporation announced the election of Martin Madaus to its board of directors, effective Thursday. Madaus brings over 30 years of experience in the diagnostics and life sciences tools industries, including leadership roles at Ortho Clinical Diagnostics, Millipore Corporation, and Roche Diagnostics North America. …

Weyerhaeuser's Q2 Earnings Preview: Key Factors Investors Should Watch

Weyerhaeuser (WY) is set to announce its Q2 2026 earnings on July 30, with EPS estimates decreasing to 8 cents and net sales projected to decline by 4.7% year-over-year. The company anticipates Timberlands and Strategic Land Solutions to perform broadly as expected, but Wood …

Schaeffler India Q2FY26 revenue rises 17.5% to ₹26,814 mn

Haemonetics Corp (HAE) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Haemonetics Corp (HAE), detailing its current risk score, beta value, and various volatility metrics. The company's risk assessment score is 6.94, ranking it 46th in the Healthcare Equipment & Supplies industry, with a beta of 0.55 indicating …

Weyerhaeuser Company (WY) Q1 2026 Earnings Report - Results, Call & Slides

Weyerhaeuser Company (WY) reported strong Q1 2026 earnings, beating both EPS and revenue estimates, with actual EPS at $0.11 against a consensus of $0.06 and actual revenue of $1.73 billion against an expected $1.72 billion. The company saw a significant 120% sequential increase in …

Haemonetics Corp. (HAZ) Q4 2026 Earnings Report - Results, Call & Slides

Haemonetics Corp. (HAZ) reported its Q4 2026 earnings, beating EPS and revenue estimates with actual EPS of €1.13 against a consensus of €1.12, and revenue of €304.05M against an expected €295.70M. The company highlighted strong organic revenue growth in plasma and blood management, full-year …

Haemonetics Corp (HAE) Income Statement

This article presents the detailed quarterly and annual income statements for Haemonetics Corp (HAE), covering financial data such as total revenue, cost of revenue, operating expenses, and net income over many fiscal periods. It also provides FAQs on how to interpret these financial statements …

Will Softer WY Earnings Expectations and Steady Payouts Shift Weyerhaeuser's Cash Flow Narrative?

Weyerhaeuser is facing softer analyst sentiment with projected year-over-year earnings and revenue declines for Q2 2026, alongside a negative Earnings ESP. Despite this, the company has maintained its US$0.21 quarterly dividend and continued share repurchases, sparking a debate on how these factors will impact …

OPINION | REX NELSON: A wall of wood

Rex Nelson discusses the economic struggles of south Arkansas despite it being in the loblolly pine belt, highlighting how forests are growing faster than they are harvested. He details Weyerhaeuser's new $500 million facility in Monticello/Warren, which will produce TimberStrand from small-diameter pines, offering …

A wall of wood

Weyerhaeuser Co. is investing $500 million in a new facility in Arkansas, aiming to boost the struggling south Arkansas economy and provide an outlet for the region's abundant timber. This development comes as concerns rise about an oversupply of timber, termed "a wall of …

Haemonetics Market Sentiment

This article analyzes the market sentiment for Haemonetics (HAE) based on analyst consensus, short interest, options flow, and insider activity. It highlights an "Outperform" consensus from analysts with an average price target of $86 and notes a declining short interest, suggesting a bullish outlook …

Weyerhaeuser (WY) Stock Looks Reasonable Despite a 22% Three Year Slide

Weyerhaeuser's stock has declined 22.1% over the last three years but now appears to be roughly fairly valued on market multiples, trading at a P/E of 43.5x. While this is above the industry average, it aligns with its peer group. The company's future valuation …

Weyerhaeuser (WY) Stock Looks Reasonable On Timber Cash Flow Outlook

Weyerhaeuser's stock appears fairly valued based on its current P/E ratio of 43.5x, which is in line with timber-focused peers and slightly below its calculated Fair Ratio of 44.5x. Despite a 22% decline over the past three years, the valuation suggests it's neither a …

Should Bearish Earnings Revisions and Negative ESP Require Action From Weyerhaeuser (WY) Investors?

Weyerhaeuser (WY) is facing bearish sentiment as analysts project a year-over-year decline in earnings and revenue for Q2 2026, coupled with a negative Earnings ESP. Despite these revisions, the company affirmed its quarterly cash dividend, raising questions about sustainability if weak demand persists. Investors …

Haemonetics Corp (HAE) Financial Health: Profitability & Balance Sheet Analysis

The article provides a financial health analysis of Haemonetics Corp (HAE), noting its stable financial status and high operating efficiency. The company's current financial score is 7.02, ranking 116 in the Healthcare Equipment & Supplies industry. Key financial highlights include a 4.76% year-over-year increase …

Haemonetics Corp (HAE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Haemonetics Corp (HAE), detailing its revenue by region. The data shows the United States as the largest contributor to revenue at $247.71M (73.08%), followed by Europe and Asia. Information regarding revenue by business segment was not disclosed.

Schaeffler India Limited Just Missed Earnings - But Analysts Have Updated Their Models